NCT00459823 2009-03-24A Dose Escalation Study of E7107 Administered IV (Bolus) on Days 1, 8, and 15 Every 28 Days to Patients With Solid TumoursEisai Inc.Phase 1 Suspended40 enrolled
NCT00499499 2009-02-04A Dose Escalation Study of E7107 Administered Intravenously on Days 1 and 8 Every 21 Days to Patients With Solid TumorsEisai Inc.Phase 1 Suspended40 enrolled